Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Uncategorized

    Uncategorized - Page 2

    AbbVie vows to keep drug price increases below 10 percent

    AbbVie vows to keep drug price increases below 10 percent

    supriya12 Jan 2017 11:20 AM IST
    AbbVie Inc Chief Executive Richard Gonzalez promised to keep all drug price increases in 2017 under 10 percent, becoming the third global drug maker...
    Merck leapfrogs rivals in lung cancer drug combination race

    Merck leapfrogs rivals in lung cancer drug combination race

    supriya12 Jan 2017 11:19 AM IST
    Merck & Co has pulled ahead of rivals in the race to combine immunotherapy with other drugs as a treatment for lung cancer, potentially giving it...
    Intas Pharmaceuticals Completes Deal to Acquire Actavis UK,Ireland Generics Businesses From Teva

    Intas Pharmaceuticals Completes Deal to Acquire Actavis UK,Ireland Generics Businesses From Teva

    supriya11 Jan 2017 11:09 AM IST
    Ahmedabad : Intas Pharmaceuticals Ltd. through its wholly-owned subsidiary Accord Healthcare Ltd. announced it has completed the deal to acquire...
    FDA Grants Bayer Priority Review for Stivarga-regorafeni for the Second-Line Systemic Treatment of Liver Cancer

    FDA Grants Bayer Priority Review for Stivarga-regorafeni for the Second-Line Systemic Treatment of Liver Cancer

    supriya11 Jan 2017 11:08 AM IST
    Whippany : Bayer announced that the U.S. Food and Drug Administration (FDA) has granted priority review status for the supplemental New Drug...
    OmniActive Health acquires 85 percent stake in Indfrag

    OmniActive Health acquires 85 percent stake in Indfrag

    supriya11 Jan 2017 11:06 AM IST
    New Delhi : OmniActive Health Technologies, which supplies ingredients to the healthcare and food industries, has acquired 85 per cent stake in...
    Online medicine sale permitted under present law: DIPP

    Online medicine sale permitted under present law: DIPP

    savita thakur thakur10 Jan 2017 2:30 PM IST
    The government said, online sale of medicines is permitted under the present law and the Health Ministry will come out with a clarification which will...
    Cipla appoints Peter Lankau as independent director

    Cipla appoints Peter Lankau as independent director

    supriya10 Jan 2017 11:32 AM IST
    New Delhi : Drug firm Cipla has appointed Peter Lankau as an independent director on its board with effect.Lankau is currently a principal of Lankau...
    Divis Laboratories files response to USFDA observations

    Divis Laboratories files response to USFDA observations

    supriya10 Jan 2017 11:32 AM IST
    New Delhi : Divis Laboratories said it has filed a detailed response within the permitted time to the observations made by the US health regulator...
    St Jude releases cyber updates for heart devices after US probe

    St Jude releases cyber updates for heart devices after US probe

    supriya10 Jan 2017 11:32 AM IST
    Abbott Laboratories (ABT.N) moved to protect patients with its St. Jude heart implants against possible cyber attacks, releasing a software patch that...
    Investigators sue GlaxoSmithKline over imprisonment in China

    Investigators sue GlaxoSmithKline over imprisonment in China

    supriya kashyap kashyap18 Nov 2016 12:34 PM IST
    Two former corporate investigators have sued GlaxoSmithKline, alleging the drug maker misled them and induced them to investigate an innocent person,...
    FDA warns against the use of homeopathic teething tablets and gels

    FDA warns against the use of homeopathic teething tablets and gels

    savita thakur thakur1 Oct 2016 2:29 PM IST
    The U.S. Food and Drug Administration is warning consumers that homeopathic teething tablets and gels may pose a risk to infants and children. The FDA...
    JB Chemicals to Move Higher Judiciary Against NGT Order

    JB Chemicals to Move Higher Judiciary Against NGT Order

    savita thakur thakur20 May 2016 3:06 PM IST
    New Delhi : JB Chemicals and Pharmaceuticals plans to appeal the orders passed by National Green Tribunal against the company's Panoli bulk drugs...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Government of India bans Ofloxacin, Ornidazole injection combination

    Government of India bans Ofloxacin, Ornidazole injection combination

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    PNB ties up with Religare Health Insurance

    PNB ties up with Religare Health Insurance

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok